Nationwide Children's News Releases

Jan 01, 0001

Hyundai Hope on Wheels Presents Nationwide Children’s Hospital with Hyundai Hope Scholar and Young Investigator Grants Totaling $500,000 to Support Pediatric Cancer Research

In the newest rounds of grants marking its 20th anniversary, Hyundai Hope On Wheels® 501(c)(3) celebrates National Childhood Cancer Awareness Month by awarding  grants totaling $500,000 to Dean Lee, MD, PhD, and Ryan Roberts, MD, PhD, physician-scientists in The Research Institute at Nationwide Children’s Hospital.

Jan 01, 0001

4-Year Study Finds No Correlation Between Head Impacts and Cognitive Outcomes in Youth Tackle Football Players

Dr. Sean Rose and colleagues collaborated with MORE Foundation, the Complex Concussion Clinic at Nationwide Children's, and other researchers to prospectively follow youth tackle football players in real time across four seasons, which can account for confounding factors. The study, recently published in JAMA Network Open, was conducted from July 2016 through January 2020, and enrolled players from four football teams. A total of 70 male players, 9-12 years of age, who were in 5th and 6th grade, volunteered to participate, with 18 completing all four years of the study.

Jan 01, 0001

PANERA’S INAUGURAL ‘CHIP IN FOR CHILDREN’S MENTAL HEALTH’ CAMPAIGN TO BENEFIT ON OUR SLEEVES MAY 9-22

Covelli Enterprises, the largest franchisee of Panera Bread, is partnering with On Our Sleeves, the movement for children’s mental health, through the launch of its inaugural Chip in for Children’s Mental Health campaign. In honor of Mental Health Awareness month, from May 9-22, a portion of proceeds from all Chocolate Chipper cookies sold at thirty-nine Covelli-owned and operated Panera Bread locations in Columbus and Central Ohio, will support this vital initiative, powered by Nationwide Children’s Hospital.

Jan 01, 0001

Investigators Develop Technique to Effectively Edit NK Cells to Target Specific Cancer Cells

Originally, NK cells seemed promising for a natural therapy to fight cancer due to their innate ability to recognize any cells expressing stress or signs of infection. But investigators quickly realized they faced three key challenges: first, it was difficult to grow a large enough number of NK cells in the lab to offer useful infusions at a reasonable cost; second, an ideal universal donor solution was needed to make NK cell products faster, more reliably and with off-the-shelf availability; and third, NK cells were resistant to genetic modifications that might help them better target specific types of cancer cells. Nationwide Children’s Hospital investigators and their collaborators painstakingly solved the first two problems over the past decade. Now, they’ve conquered the third.

Jan 01, 0001

A Single-Dose Cancer Immunotherapy via Gene Transfer

Researchers at Nationwide Children’s Hospital report proof-of-principle results for a new gene therapy cancer treatment. The off-the-shelf, single-dose immunotherapy serves as an alternative to CAR-T therapy and can be engineered to be on-demand.